logo
episode-header-image
Aug 2023
28m 37s

What difference could new Alzheimer’s di...

Bbc Radio 4
About this episode
tail spinning
Up next
Oct 27
How self-injecting culture is bringing new dangers
We investigate how self-injecting is leading to people being hospitalised and is creating new challenges for support services.Laura Foster meets NHS endocrinologist Dr Bonnie Grant, criminologist at the University of Lincoln Dr Luke Turnock and Jon Findlay, Harm Reduction Lead at ... Show More
27m 45s
Oct 20
Can full body MRI scans be good for our health?
We investigate the growing business of full-body MRI scans. The clinics argue they can spot diseases and problems early before people feel unwell - but critics say it’s a waste of thousands of pounds and creates unnecessary anxiety about things that may never become a problem. La ... Show More
28m 11s
Sep 22
Is inflammation behind all chronic disease?
Right now, research is gathering pace in revolutionising our understanding of inflammation, which could transform the treatment of so many chronic diseases - cancer, Alzheimer's, heart disease, depression, type 2 diabetes and many more. So, what is inflammation, how is it implica ... Show More
27m 55s
Recommended Episodes
Apr 2023
Audio long read: Conquering Alzheimer’s — a look at the therapies of the future
Last year, researchers announced that the Alzheimer’s drug lecanemab lowered the amount of amyloid protein plaques associated with the disease in the brains of participants in a clinical trial, and slowed their cognitive decline.Now, researchers are looking to drug combinations, ... Show More
17m 31s
Jul 2023
How close are we to ending Alzheimer's?
A new drug, Donanemab, has been hailed as a turning point in the fight against Alzheimer's after a global trial confirms it slows cognitive decline.One trial was shown to have “significantly slowed” the progression of the disease—by 35%.Earlier this year, Lecanemab, the first dru ... Show More
48m 39s
Mar 2023
How Well Does A New Alzheimer's Drug Work For Those Most At Risk?
A new drug for Alzheimer's disease, called lecanemab, got a lot of attention earlier this year for getting fast-tracked approval based on a clinical trial that included nearly 1,800 people. It was the most diverse trial for an Alzheimer's treatment to date, but still not enough t ... Show More
13m 46s
Nov 2024
Why There’s More Hope for Alzheimer’s
For the nearly 7 million Americans living with Alzheimer’s, progress on treatments has felt painfully slow and incremental at best…until now. Dr. Sanjay Gupta traveled the country meeting people who have slowed, prevented, and in some cases even reversed the spread of Alzheimer’s ... Show More
30m 50s
Jun 2021
Alzheimer’s drug has experts divided; rising ICE use in Australia; the disappointing results of a study aimed at improving ovarian cancer survival rates
This week, the first of a new series on substance use and what you need to know about ICE - crystal meth. Does early diagnosis of ovarian cancer through screening make a difference to survival rates? And the search for an Alzheimer's disease treatment is as controversial as ever. ... Show More
35m 10s
Nov 2023
Alzheimer’s Update, Part 2
This episode explores the current state of research on the multiple likely mechanisms of Alzheimer’s disease as well as promising treatments and diagnostics. A full transcript of this episode is available at nejm.org/doi/full/10.1056/NEJMp2309944. 
54 m
Jul 2023
AAN President Elect Testified Before House Subcommittee on New Alzheimer Treatment
Dr. Stacey Clardy talks with Dr. Natalia Rost about her experience speaking before the House of Representatives on the approval of lecanemab for the treatment of early Alzheimer disease. Visit NPUb.org/Podcast for associated article links. This episode was sponsored by the ExTING ... Show More
14m 27s
Nov 2023
New psychosis drug, why its hard to recall 2021, and counselling in later life
A new medication for psychosis is on the horizon. It's called KarXT and it could mean fewer side effects as well as finally some relief from difficulties with attention, concentration and memory - these are the symptoms patients often report as having the greatest impact on their ... Show More
27m 54s
May 2022
Liana G. Apostolova, MS, MD, FAAN - Accelerating Progress in the Treatment of Alzheimer’s Disease: How Can We Achieve Timely and Accurate Neuropathological Diagnosis and Precision Management of Mild Cognitive Impairment in Early Alzheimer’s Disease?
Go online to PeerView.com/JYU860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Alzheimer’s disease (AD) is a devastating, progressive neurodegenerative disorder affecting 10% of people over age 65 and increasing in global prev ... Show More
1h 44m